@CARE-PF (@care_pf) 's Twitter Profile
@CARE-PF

@care_pf

Official account for the Canadian Registry for Pulmonary Fibrosis (CARE-PF) - prospective, multi-centre 🇨🇦 registry for pts w/ interstitial lung disease

ID: 1582010296662724608

calendar_today17-10-2022 14:07:11

34 Tweet

199 Followers

153 Following

Kerri Johannson MD MPH (@kerriberrikerri) 's Twitter Profile Photo

We developed a knowledge-sharing tool (hplung.com) listing exposures associated with #HP 👏 Hayleybarnes Jesse Lu 👏 In this #OpenAccess article, we explain why, how, and the importance of digital scholarship Thanks ATS Scholar 😊 atsjournals.org/doi/full/10.34…

We developed a knowledge-sharing tool (hplung.com) listing exposures associated with #HP 
👏 <a href="/hayleynbarnes/">Hayleybarnes</a> <a href="/jialuolu/">Jesse Lu</a> 👏

In this #OpenAccess article, we explain why, how, and the importance of digital scholarship 
Thanks <a href="/ATSScholar/">ATS Scholar</a> 😊

atsjournals.org/doi/full/10.34…
Gillian Goobie, MD PhD (@gilliangoobie) 's Twitter Profile Photo

Thanks @EnvirHealthNews for highlighting our JAMA Internal Medicine manuscript & for helping to make our findings accessible to a general audience! Our pts deserve #CleanAirNow & clinicians, scientists, pts, & communities can partner to achieve this goal! ehn.org/respiratory-di…

Kerri Johannson MD MPH (@kerriberrikerri) 's Twitter Profile Photo

Gisli Jenkins Anna Hoffmann-Vold REMAP-ILD Naftali Kaminski Leticia Kawano-Dourado Action for Pulmonary Fibrosis NIHR Research Just out in ERS publications from @CARE-PF and Austin #ILD registry from Dr. Yet Khor et al. Same for #IPF clinical trials! Single changes in criteria vastly change eligibility AND! AND! different criteria show different trajectories #ChooseWisely pubmed.ncbi.nlm.nih.gov/36858445/

<a href="/IPFdoc/">Gisli Jenkins</a> <a href="/hoffmann_vold/">Anna Hoffmann-Vold</a> <a href="/REMAP_ILD/">REMAP-ILD</a> <a href="/KaminskiMed/">Naftali Kaminski</a> <a href="/leticiakawano/">Leticia Kawano-Dourado</a> <a href="/ActionPFcharity/">Action for Pulmonary Fibrosis</a> <a href="/NIHRresearch/">NIHR Research</a> Just out in <a href="/ERSpublications/">ERS publications</a> from <a href="/CARE_PF/">@CARE-PF</a> and Austin #ILD registry from Dr. Yet Khor et al. 
Same for #IPF clinical trials! 
Single changes in criteria vastly change eligibility AND! AND! different criteria show different trajectories
#ChooseWisely 
pubmed.ncbi.nlm.nih.gov/36858445/
Gisli Jenkins (@ipfdoc) 's Twitter Profile Photo

Great to have Chris Ryerson come and deliver the MTW Seminar today. imperial.ac.uk/mtw-centre-fib… Fantastic to hear about the success of @CARE-PF Kerri Johannson MD MPH

Great to have Chris Ryerson come and deliver the MTW Seminar today. imperial.ac.uk/mtw-centre-fib… 
Fantastic to hear about the success of <a href="/CARE_PF/">@CARE-PF</a> <a href="/KerriBerriKerri/">Kerri Johannson MD MPH</a>
Kerri Johannson MD MPH (@kerriberrikerri) 's Twitter Profile Photo

Sex-and Race-based Differences in Treatment of #ILD in North America & Australasia in CHEST 🌟Multi-registry collaboration b/w @CARE-PF PCCM UChicago & Australasian ILD registries🌟 ➡️Differences in differences... Free d/l til June 1st w link: 👇authors.elsevier.com/c/1gv8R2p-l9A1r

Sex-and Race-based Differences in Treatment of #ILD in North America &amp; Australasia in <a href="/accpchest/">CHEST</a>

🌟Multi-registry collaboration b/w <a href="/CARE_PF/">@CARE-PF</a> <a href="/UChicagoPCCM/">PCCM UChicago</a> &amp; Australasian ILD registries🌟
➡️Differences in differences...

Free d/l til June 1st w link: 👇authors.elsevier.com/c/1gv8R2p-l9A1r
Kerri Johannson MD MPH (@kerriberrikerri) 's Twitter Profile Photo

Dr. Stacey Lok gives an outstanding presentation at #ATS2023 🌟 Organic exposures are associated with -mosaic attenuation -gas trapping -3-density pattern 35% of ‘typical fHP’ HRCTs are not fHP 80% of ‘fHP compatible’ are not fHP CT pattern needs re-naming 😳 Stacey D @CARE-PF

Dr. Stacey Lok gives an outstanding presentation at #ATS2023 🌟
Organic exposures are associated with
-mosaic attenuation
-gas trapping 
-3-density pattern 

35% of ‘typical fHP’ HRCTs are not fHP
80% of ‘fHP compatible’ are not fHP
CT pattern needs re-naming 😳
<a href="/d_slok/">Stacey D</a> <a href="/CARE_PF/">@CARE-PF</a>
Kerri Johannson MD MPH (@kerriberrikerri) 's Twitter Profile Photo

Today’s 🇨🇦 #ILD Posters #ATS2023 Albina Tyker, MD ➡️ SpO2 recovery post 6MWT ass’d w/ disease severity🚶‍♀️ Leigh Minuk 10% of ILD Unclassifiable; ⬆️ odds w/ atypical CT & ⬆️ age Amanda Grant-Orser Patient + MD perceptions differ; communication 🗝️ Dr. Mira Donaldson: SpO2 vs SaO2 similar 👍

Today’s 🇨🇦 #ILD Posters #ATS2023
<a href="/albina_tyker/">Albina Tyker, MD</a> ➡️ SpO2 recovery post 6MWT ass’d w/ disease severity🚶‍♀️
<a href="/LeighMinuk/">Leigh Minuk</a> 10% of ILD Unclassifiable; ⬆️ odds w/ atypical CT &amp; ⬆️ age 
<a href="/agrantorser/">Amanda Grant-Orser</a> Patient + MD perceptions differ; communication 🗝️
Dr. Mira Donaldson: SpO2 vs SaO2 similar 👍
veronica.sa.m (@veronicasam940) 's Twitter Profile Photo

Excited to share our paper “Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort” @CARE-PF @kerriberrikerri Stacey D Jolene H Fisher Shane Shapera Gillian Goobie, MD PhD U of S CoM Office of the Vice-Dean Research #ILD jtd.amegroups.com/article/view/7… Journal of Thoracic Disease

Kerri Johannson MD MPH (@kerriberrikerri) 's Twitter Profile Photo

What #HRCT features define UIP vs fHP and how do these align with MDD-diagnoses in #ILD? Dr. Daniel Marinescu (rising ⭐️) et al. address this in CHEST® Journal using data from @CARE-PF Free access for next 50 days using link 👇 sciencedirect.com/science/articl…

What #HRCT features define UIP vs fHP and how do these align with MDD-diagnoses in #ILD?

Dr. Daniel Marinescu (rising ⭐️) et al. address this in <a href="/journal_CHEST/">CHEST® Journal</a> using data from <a href="/CARE_PF/">@CARE-PF</a> 

Free access for next 50 days using link 👇
sciencedirect.com/science/articl…